We are a global biopharmaceutical company focused on human health. We help prevent illness with vaccines, provide innovative treatments to manage pain and to prevent suffering.
Sanofi Genzyme is the speciality care global business unit of Sanofi, focused on immunology, multiple sclerosis, oncology, rare diseases and rare blood disorders.
Sanofi Genzyme Oncology believes that people with cancer and their healthcare providers deserve more – more options, more support, more life.
There are an estimated 35,000 people living with secondary breast cancer in the UK. In around 5% of women, breast cancer has already spread by the time it is diagnosed.1
Driven by our commitment to patients, we strive to develop strong relationships with our patient communities, listening to their perspectives so that we can truly understand their needs.
We recognise the incredible burden that breast cancer places on individuals and the people who care for them. Their stories motivate and inspire us in our mission to develop novel treatment options, expand access to therapies, provide patient support services, and partner with patient organizations around the world to fully understand both patient and caregiver needs.
We are working with healthcare professionals, people with cancer, advocates and policymakers to optimise cancer care and empower people.
Sanofi Genzyme are supporting this meeting through sponsorship and have had no control over the agenda, educational content or logistics of this event.
1 https://breastcancernow.org/about-us/media/facts-statistics Accessed September 2021
MAT-GB-2105165(v2.0) | February 2022